Pancreatin Zdorovye forte 14000 enteric-coated tablets 50 pieces

• active ingredient: pancreatin;
• 1 tablet contains 384 mg of pancreatin with an activity of at least 10,000 amylolytic IU (Ph. Eur. U.), 14,000 lipolytic IU, 800 proteolytic IU;
• excipients: lactose, monohydrate; microcrystalline cellulose, croscarmellose sodium, crospovidone, povidone, colloidal anhydrous silica, magnesium stearate, polyethylene glycol, azorubine (E 122); dry mixture “Acryl-eze white”, containing talc, titanium dioxide (E 171), methacrylate copolymer, sodium lauryl sulfate, sodium bicarbonate, silicon dioxide.

Hypersensitivity to porcine pancreatin/other components of the drug, acute pancreatitis, exacerbation of chronic pancreatitis, intestinal obstruction.

On the part of the digestive system: very rarely – nausea, vomiting, flatulence, diarrhea, discomfort in the epigastric region, change in the nature of stools.

Hypersensitivity reactions (including rash, itching, sneezing, lacrimation, bronchospasm, urticaria, anaphylactic reactions), perianal irritation are possible.

Take orally during or immediately after meals, the tablets should be swallowed whole, without chewing, with plenty of liquid (water, fruit juices). The dosage of the drug is based on the individual needs of the patient and depends on his age, the degree of digestive disorders and the composition of the food.

It is recommended to take 1-2 tablets (14000-28000 IU lipase) with each meal. However, it is possible that some patients may need to increase the dose by 1.5-2 times or even more to eliminate steatorrhea and maintain proper nutritional status. It is not recommended to exceed the dose of 15000-20000 IU lipase/kg body weight/day.

The duration of treatment can vary from several days (in case of indigestion due to excessive food consumption) to several months or even years (if permanent replacement therapy is necessary).

With prolonged use, simultaneous administration of iron preparations is recommended.

The drug contains lactose, therefore, if the patient has been diagnosed with intolerance to some sugars, you should consult a doctor before taking this drug.

Azorubine (E 122) may cause allergic reactions.

Use during pregnancy or breastfeeding

The safety of pancreatin use during pregnancy has not been sufficiently studied.

During pregnancy or breastfeeding, the drug should be taken as prescribed by a doctor if the expected benefit to the mother outweighs the potential risk to the fetus/child.

Children

The drug is recommended for use in children aged 4 years and older.

Ability to influence reaction speed when driving vehicles or other mechanisms

No effect.

Symptoms: hyperuricosuria, hyperuricemia; in children – constipation.

Treatment: drug withdrawal, adequate hydration, symptomatic therapy.

When using the drug, it is possible to reduce the absorption of iron, folic acid, reduce the hypoglycemic effect of acarbose. When used simultaneously with antacids containing calcium carbonate and/or magnesium hydroxide, with tannin, alcohol-containing products, the effectiveness of pancreatin is reduced.

Store in original packaging at a temperature not exceeding 25 °C. Keep out of the reach of children.